Joaquim Miguel Oliveira

About

J. Miguel Oliveira BSc, PhD, FBSE (Portuguese, M, 47 years old) is a Principal Investigator with Habilitation at the 3B's Research Group, member of the PT Government Associate Laboratory ICVS/3B’s (https://3bs.uminho.pt/people/94) and Institute 3Bs (I3Bs), University of Minho (Portugal). He is the Vice President of I3Bs, President Elect of the Scientific Council of I3Bs, and Past-Director of Pre-Clinical Research at the FIFA MEDICAL CENTER, Estádio do Dragão, Porto, PT (2013-2020). Currently, he is a Lecturer in Doctoral Program in Tissue Engineering, Regenerative Medicine and Stem Cells (TERM&SC) at UMinho, PT (since Dec. 2013). He was also an invited lecturer at the Faculty of Medicine, U. Porto (2013-2019). Over the years, he has focused his work on the field of biomaterials for tissue engineering, nanomedicine, stem cells, and cell/drug delivery. He also set up a new research line within the ICVS/3B’s on 3D in vitro models for cancer research. As a result of his proficiency, he has published so far more than 500 scientific contributions in scientific journals with the referee. Miguel Oliveira has 24 patents (filled & submitted), published 12 books (plus 4 in preparation), 18 special issues/topic collections in scientific journals, and more than 130 book chapters in books with international circulation. He has participated in more than 700 communications in national/international conferences and has been invited/keynote speaker in more than 100 plenary sessions and seminars. He has an D-index of 63, h-index of 80, i10 of 300, and received more than 23500 citations. Since 2020, his contributions have been consistently cited more than 2000 times per year. He has been awarded several prizes including the prestigious “Investigador FCT 2012 and Investigador FCT 2015” attributed by FCT (Portugal), and Jean Leray Award 2015 from European Society for Biomaterials for Young Scientists for Outstanding Contributions within the field of Biomaterials. In Nov. 2023, Dr. Oliveira has been appointed Fellow Biomaterials Science and Engineering (FBSE) for the excellent professional standing and high achievements in the field of biomaterials science and engineering. He is very active on the elaboration and scientific coordination of several PT and international funded projects. In addition, he was member of the National Ethics Committee for Clinical Trials from Serviço Nacional de Saúde (SNS) (PORTUGAL) (Jan. 2021- Aug. 2024). He is the Editor-in-chief of the In vitro Models Journal (Springer Nature, first IF of 2.4 in 2024). He is one of the Editors of the Book Series on Biomaterials, Bioengineering and Sustainability (Springer). He also integrates the advisory /editorial board of the Journals Biomaterials Research, Bio-Design and Manufacturing, International Journal of Bioprinting, Journal of Materials Science: Materials in Medicine, Materials (MDPI), International Journal of Tissue Engineering, Journal of Composites and Biodegradable Polymers, Journal ISRN Biomaterials, The Journal of Experimental Orthopaedics, Journal “Recent Patents on Corrosion Science”, and has several editorial roles in Frontiers. He is referee in more than 50 international journals. He is the coordinator of the project EngVIPO - Engineering Vascularized Implants for Personalised Osteochondral Tissue Regeneration: From medical imaging to pre-clinical validation (https://engvipo.i3bs.eu/) funded from the European Union's Horizon Europe (HORIZON-MSCA-2023-SE-01-01) under the Grant Agreement Number 101183041. In 2020-21, he was listed among the TOP50 worldwide experts in tissue engineering and cartilage by EXPERTSCAPE (https://expertscape.com/ex/tissue+engineering), and has been listed in the World TOP2% (Career) most cited researchers (2021-2023). In 2022 and 2023, he was listed in the TOP1% (Yearly) most cited researchers.

Education